KM12 cell line细胞株 BioVector NTCC质粒载体菌种细胞基因保藏中心

KM12 cell line细胞株 BioVector NTCC质粒载体菌种细胞基因保藏中心 Cell line name KM12 Synonyms KM-12; KM.12 Accession CVCL_1331 Resource Identification Initiative To cite this cell line use: KM12 (RRID:CVCL_1331) Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: JFCR39 cancer cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Doubling time: 23 hours (PubMed=25984343); 23.7 hours (NCI-DTP). Microsatellite instability: Instable (MSI-high) (PubMed=25926053; Sanger). Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep quantitative phosphoproteome analysis. Omics: Deep quantitative proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: 'KIM12' in GEO GSM846361. Disease Colon carcinoma (NCIt: C4910) Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606) Hierarchy Children: CVCL_9547 (KM12-C); CVCL_5946 (KM12-L4); CVCL_J258 (KM12-Luc) Sex of cell Sex undetermined Category Cancer cell line STR profile Source(s): Cosmic-CLP; PubMed=11416159; PubMed=19372543; PubMed=25877200 Markers: Amelogenin X CSF1PO 10,12 D13S317 12,15 D16S539 11 D18S51 13 D19S433 11,14 D21S11 27 D3S1358 14 D5S818 10,17 (Cosmic-CLP) 10,18 (PubMed=19372543) 10 (PubMed=25877200) D7S820 8,9 (Cosmic-CLP) 8,8.3 (PubMed=19372543; PubMed=25877200) D8S1179 11,13 FGA 20,22 Penta D 12 Penta E 14,18 TH01 9.3 TPOX 11,12 vWA 17 (PubMed=11416159) 17,19 (Cosmic-CLP; PubMed=19372543; PubMed=25877200) Web pages https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm https://strap.nci.nih.gov/celline_detail.php?sample_id=21 http://tcpaportal.org/mclp/ Publications PubMed=2041050; DOI=10.1093/jnci/83.11.757 Monks A., Scudiero D.A., Skehan P., Shoemaker R.H., Paull K., Vistica D.T., Hose C., Langley J., Cronise P., Vaigro-Wolff A., Gray-Goodrich M., Campbell H., Mayo J., Boyd M. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst. 83:757-766(1991) BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心www.biovector.net [Supplier来源] http://www.biovector.net